WASHINGTON - A panel of outside advisers to the U.S. Food and Drug Administration on Friday will review data and vote on whether the millions of Americans who received the single-dose Johnson & Johnson COVID-19 vaccine should get a booster shot.
The committee, which voted unanimously on Thursday to recommend a half-dose of Moderna’s COVID-19 booster for some Americans, is scheduled to reconvene from 8:30 a.m.
to 5 p.m. ET and be streamed online.The FDA’s advisers will hear evidence for the J&J booster shot as well as look into the safety and effectiveness of mixing and matching different brands of vaccines — something regulators have not endorsed so far.U.S.